Industry invests in supply chain strategies for low-income countries
Pharma companies have improved or maintained standards for effective drug recalls, product packaging and managing supply in LMICs, according to the report.
Pharma companies have improved or maintained standards for effective drug recalls, product packaging and managing supply in LMICs, according to the report.
Cambrex is set to acquire Avista and enter the market of early stage small molecule development and testing.
The new technology, Pattern to Knowledge (P2K), reduces “bottlenecks” in drug research by examining bio-sequences in a shorter time frame.
World Courier has made a multimillion-dollar investment in its supply chain technology to help meet the expanding needs of the pharmaceutical industry.
PHARMA INTEGRATES
Rather than limit health care data collection, the industry should focus on ensuring those data sets are used ‘in the most appropriate way,’ according to Health iQ chief commercial officer.
Takeda’s aim to acquire Shire for $62bn received a boost after regulators vote positively to approve the transaction following the divestment of Shire’s IBD drug.
Mylan stated it is undertaking ‘comprehensive restructuring’ of the facility, after a recent warning letter issued to the company by the FDA.